• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors

    7/30/25 11:00:00 AM ET
    $EVR
    $LIFE
    $ATH
    Investment Managers
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $EVR alert in real time by email

    AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced the appointment of William J. Wheeler to its Board of Directors. Mr. Wheeler, a seasoned executive with deep expertise across insurance, retirement services, and investment banking, joins Ethos' distinguished board, further strengthening Ethos' governance and strategic guidance as the company continues its rapid growth and innovation.

    Mr. Wheeler brings more than three decades of leadership experience in the financial services industry. He most recently served as Vice Chairman of Athene Holding Ltd. (NYSE:ATH), a leading retirement services company and subsidiary of Apollo Global Management, following seven years as Athene's President. Prior to Athene, Mr. Wheeler served as President of the Americas for MetLife, overseeing the company's insurance and retirement business across the United States and Latin America, and earlier served as MetLife's Chief Financial Officer. He currently serves as a director of Evercore Inc. (NYSE:EVR), chairing its Audit Committee and serving as a member of its Compensation Committee. Mr. Wheeler previously served on the boards of directors of Athora Holding Ltd. and Venerable Holdings Inc., both private insurance companies. He has also served on the American Council of Life Insurers. Mr. Wheeler holds a Bachelor of Arts degree from Wabash College, where he is the Chairman of its board of trustees, and a Master of Business Administration from Harvard Business School.

    "I'm excited to join an organization which I believe will have a significant impact on how people obtain life insurance and other financial services," said Mr. Wheeler.

    With his addition, Mr. Wheeler joins a board that, along with co-founders Peter Colis and Lingke Wang, includes Sequoia Capital's Roelof Botha, Accel's Nate Niparko, Guidewire Software's Priscilla Hung, Twilio's Khozema Shipchandler, and former PayPal executive John Kunze.

    "Bill is a seasoned operator with deep expertise in the insurance and retirement industries, and his track record of strategic leadership at some of the most respected companies in financial services will be invaluable to Ethos as we continue to expand our impact," said Peter Colis, CEO of Ethos. "We are honored to welcome him to our Board, where his perspective and guidance will help us build on our momentum and deliver even greater value to the families we serve."

    Ethos leverages proprietary technology and predictive and real-time data to remove the friction from the life insurance application process, enabling customers to apply for coverage with a fully digital application with a few health questions that provides customers with decisions in minutes, without lengthy and invasive medical exams. By streamlining the process, Ethos helps more families gain peace of mind and long-term financial stability.

    About Ethos

    Ethos is a leading life insurance technology company on a mission to protect families by democratizing access to life insurance and empowering agents at scale. With its robust three-sided technology platform, Ethos is transforming the life insurance experience for consumers, agents, and carriers alike. Ethos offers instant, accessible products and a seamless online process that requires no medical exams and just a few health questions — eliminating traditional barriers and making it easier than ever for everyone to protect their families. Each month, Ethos issues billions in coverage, redefining how life insurance is bought, sold, and underwritten.

    Learn more at ethos.com.

    Press Contact:

    Allyson Savage

    [email protected]



    Primary Logo

    Get the next $EVR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVR
    $LIFE
    $ATH

    CompanyDatePrice TargetRatingAnalyst
    Evercore Inc.
    $EVR
    10/9/2025$400.00Buy
    Deutsche Bank
    Evercore Inc.
    $EVR
    10/3/2025$358.00Market Perform
    BMO Capital Markets
    Evercore Inc.
    $EVR
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    Evercore Inc.
    $EVR
    6/23/2025$312.00Equal-Weight → Overweight
    Morgan Stanley
    Evercore Inc.
    $EVR
    4/8/2025$230.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Evercore Inc.
    $EVR
    4/7/2025$306.00 → $173.00Overweight → Equal-Weight
    Morgan Stanley
    Evercore Inc.
    $EVR
    12/20/2024$269.00 → $339.00Mkt Perform → Outperform
    Keefe Bruyette
    Evercore Inc.
    $EVR
    9/12/2024$258.00Equal Weight
    Wells Fargo
    More analyst ratings

    $EVR
    $LIFE
    $ATH
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Evercore Inc.

    SCHEDULE 13G - Evercore Inc. (0001360901) (Subject)

    11/12/25 9:33:34 AM ET
    $EVR
    Investment Managers
    Finance

    SEC Form 10-Q filed by Evercore Inc.

    10-Q - Evercore Inc. (0001360901) (Filer)

    11/5/25 4:07:22 PM ET
    $EVR
    Investment Managers
    Finance

    Evercore Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Evercore Inc. (0001360901) (Filer)

    10/29/25 6:45:20 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Lars Ingemarsson Joins Evercore as Senior Managing Director and Head of Evercore's Nordic Region

    Evercore announced today that Lars Ingemarsson has joined the firm as senior managing director and head of the firm's Nordic region. His appointment marks a significant step in the firm's ongoing international expansion. Mr. Ingemarsson will be based in Stockholm, where Evercore is establishing its first office in the Nordic region. Mr. Ingemarsson will lead the firm's strategic growth across the region. He will collaborate closely with Evercore's existing advisory team in EMEA, the Americas and Asia to drive the buildout of the firm's Nordic presence, deepen relationships with clients and advance the firm's position as a trusted advisor across the area. He is joined by Kristoffer Elshult

    11/19/25 3:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Keith Prusek and Hugh Rabb Join Evercore as Senior Managing Directors in the Transportation Investment Banking Group

    Evercore announced today that Keith Prusek and Hugh Rabb have joined the firm as senior managing directors in its transportation investment banking group. Both will be based in Richmond, Virginia, where Evercore has opened a new office as part of its ongoing initiative to further expand its presence and capabilities across the United States. Mr. Prusek and Mr. Rabb will lead the logistics coverage effort and work closely with Evercore's established transportation team in New York. "We are excited to welcome Keith and Hugh to Evercore as we continue to strengthen our transportation practice. Their deep expertise, combined with the opening of our Richmond office, underscores our commitmen

    11/3/25 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Denyes Nancy bought $9,276 worth of shares (5,000 units at $1.86), increasing direct ownership by 29% to 22,267 units (SEC Form 4)

    4 - aTYR PHARMA INC (0001339970) (Issuer)

    6/6/24 8:26:55 AM ET
    $LIFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Coughlin Timothy bought $87,500 worth of shares (50,000 units at $1.75) (SEC Form 4)

    4 - aTYR PHARMA INC (0001339970) (Issuer)

    6/3/24 4:21:12 PM ET
    $LIFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Broadfoot Jill Marie bought $8,950 worth of shares (5,000 units at $1.79), increasing direct ownership by 22% to 27,960 units (SEC Form 4)

    4 - aTYR PHARMA INC (0001339970) (Issuer)

    6/3/24 8:38:39 AM ET
    $LIFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $EVR
    $LIFE
    $ATH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Founder and Senior Chairman Altman Roger C

    4 - Evercore Inc. (0001360901) (Issuer)

    11/10/25 5:06:19 PM ET
    $EVR
    Investment Managers
    Finance

    Director Harris Gail Block gifted 33 units of Shares of Class A common stock, decreasing direct ownership by 0.08% to 39,787 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    9/9/25 5:02:44 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form 4 filed by Founder and Senior Chairman Altman Roger C

    4 - Evercore Inc. (0001360901) (Issuer)

    8/25/25 4:34:13 PM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Deutsche Bank initiated coverage on Evercore with a new price target

    Deutsche Bank initiated coverage of Evercore with a rating of Buy and set a new price target of $400.00

    10/9/25 8:26:37 AM ET
    $EVR
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Evercore with a new price target

    BMO Capital Markets initiated coverage of Evercore with a rating of Market Perform and set a new price target of $358.00

    10/3/25 8:39:40 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore downgraded by Citizens JMP

    Citizens JMP downgraded Evercore from Mkt Outperform to Mkt Perform

    7/14/25 8:39:26 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Leadership Updates

    Live Leadership Updates

    View All

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Lars Ingemarsson Joins Evercore as Senior Managing Director and Head of Evercore's Nordic Region

    Evercore announced today that Lars Ingemarsson has joined the firm as senior managing director and head of the firm's Nordic region. His appointment marks a significant step in the firm's ongoing international expansion. Mr. Ingemarsson will be based in Stockholm, where Evercore is establishing its first office in the Nordic region. Mr. Ingemarsson will lead the firm's strategic growth across the region. He will collaborate closely with Evercore's existing advisory team in EMEA, the Americas and Asia to drive the buildout of the firm's Nordic presence, deepen relationships with clients and advance the firm's position as a trusted advisor across the area. He is joined by Kristoffer Elshult

    11/19/25 3:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Keith Prusek and Hugh Rabb Join Evercore as Senior Managing Directors in the Transportation Investment Banking Group

    Evercore announced today that Keith Prusek and Hugh Rabb have joined the firm as senior managing directors in its transportation investment banking group. Both will be based in Richmond, Virginia, where Evercore has opened a new office as part of its ongoing initiative to further expand its presence and capabilities across the United States. Mr. Prusek and Mr. Rabb will lead the logistics coverage effort and work closely with Evercore's established transportation team in New York. "We are excited to welcome Keith and Hugh to Evercore as we continue to strengthen our transportation practice. Their deep expertise, combined with the opening of our Richmond office, underscores our commitmen

    11/3/25 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Financials

    Live finance-specific insights

    View All

    Evercore Reports Third Quarter 2025 Results; Quarterly Dividend of $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   Third Quarter Results   Year to Date Results   U.S. GAAP   Adjusted   U.S. GAAP   Adjusted   Q3 2025 Q3 2024   Q3 2025 Q3 2024   YTD 2025 YTD 2024   YTD 2025 YTD 2024 Net Revenues ($ mm) $ 1,038.9   $ 734.2     $ 1,047.1   $ 739.5     $ 2,567.5   $ 2,004.3     $ 2,585.8   $ 2,022.1   Operating Income ($ mm) $ 216.2   $

    10/29/25 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore to Announce Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025

    Evercore (NYSE:EVR) will release its third quarter 2025 financial results on Wednesday, October 29, 2025 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's third quarter 2025 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 274-8461 (toll-free domestic) or (203) 518

    10/15/25 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore Reports Second Quarter 2025 Results; Quarterly Dividend of $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   Second Quarter Results   Year to Date Results   U.S. GAAP   Adjusted   U.S. GAAP   Adjusted   Q2 2025 Q2 2024   Q2 2025 Q2 2024   YTD 2025 YTD 2024   YTD 2025 YTD 2024 Net Revenues ($ mm) $ 833.8   $ 689.2     $ 838.9   $ 695.3     $ 1,528.7   $ 1,270.0     $ 1,538.8   $ 1,282.6   Operating Income ($ mm) $ 150.4  

    7/30/25 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evercore Inc.

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    10/4/24 2:32:45 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by aTyr Pharma Inc. (Amendment)

    SC 13G/A - aTYR PHARMA INC (0001339970) (Subject)

    2/14/24 1:43:55 PM ET
    $LIFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Evercore Inc. (Amendment)

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    2/13/24 5:04:33 PM ET
    $EVR
    Investment Managers
    Finance